Phase I Study Of Intravenously Administered ATI-1123, A Liposomal Docetaxel Formulation In Patients With Advanced Solid Tumors
Devalingam Mahalingam, John J. Nemunaitis, Laeeq Malik, John Sarantopoulos, Steven Weitman, Kamalesh Sankhala, Jessica Hart, Ahmed Kousba, Nicole S. Gallegos, Gavin Anderson, John Charles, Jon M. Rogers, Neil N. Senzer, Alain C. Mita
Twitter
Facebook
LinkedIn
Email